GSK said its shot, the world’s first authorized RSV vaccine, showed protection in older adults for two seasons after a single dose.
RSV Vaccine For Adults Gives Long-Term Protection, GSK Says After Late-Stage Trial
GSK said its shot, the world’s first authorized RSV vaccine, showed protection in older adults for two seasons after a single dose.